Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00432458 · OUTCOME

Duration of Response (Complete Response, Partial Response, and Very Good Partial Response)

Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma · Source last updated 2012-07-04

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
years
Interval / dispersion
95% Confidence Interval
Time frame
time from start of response to progression (up to 5 years)

What was measured

Duration of response (DOR) is defined as the time from first documentation of response (CR, VGPR or PR) to disease progression. The median DOR with 95% CI was estimated using the Kaplan Meier method

Analysis population: Participants who achieved a confirmed response (CR, VGPR, or PR) as described above were analyzed.

Groups in this outcome

Arm I: Thal/ZLD

Thalidomide (Thal) + Zolendronic acid (ZLD)

Arm II: ZLD

Zoledronic acid (ZLD)

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Arm I: Thal/ZLD13
Arm II: ZLD0

Reported measurements

Source class 1
Values in years · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Arm I: Thal/ZLD3.3Not reported1.1NAThe upper limit was not calculable because an insufficient number of participants reached the event at the final time point for assessment
Complete source fields
classes
  1. categories
    1. measurements
      1. comment
        The upper limit was not calculable because an insufficient number of participants reached the event at the final time point for assessment
        group Id
        OG000
        lower Limit
        1.1
        upper Limit
        NA
        value
        3.3
denoms
  1. counts
    1. group Id
      OG000
      value
      13
    2. group Id
      OG001
      value
      0
    units
    Participants
description
Duration of response (DOR) is defined as the time from first documentation of response (CR, VGPR or PR) to disease progression. The median DOR with 95% CI was estimated using the Kaplan Meier method
dispersion Type
95% Confidence Interval
groups
  1. description
    Thalidomide (Thal) + Zolendronic acid (ZLD)
    id
    OG000
    title
    Arm I: Thal/ZLD
  2. description
    Zoledronic acid (ZLD)
    id
    OG001
    title
    Arm II: ZLD
param Type
MEDIAN
population Description
Participants who achieved a confirmed response (CR, VGPR, or PR) as described above were analyzed.
reporting Status
POSTED
time Frame
time from start of response to progression (up to 5 years)
title
Duration of Response (Complete Response, Partial Response, and Very Good Partial Response)
type
SECONDARY
unit Of Measure
years

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice